Skip to main content
. 2021 Oct 14;28(5):4157–4166. doi: 10.3390/curroncol28050352

Table 2.

Adverse events during the follow-up period (>10%).

Adverse Events Any Grade (%) Grade ≥ 3 (%)
Hypertension 17 (42.5%) 3 (7.5%)
Proteinuria 16 (40.0%) 6 (15.0%)
Edema 15 (37.5%) 1 (2.5%)
Fever 13 (32.5%) -
Fatigue 11 (27.5%) -
Pruritus 10 (25.0%) -
Decreased appetite 7 (17.5%) 1 (2.5%)
Hand-foot skin reaction 5 (12.5%) -
Nasal bleeding 5 (12.5%) 1 (2.5%)
Rash 4 (10.0%) -
Thyroid function abnormality 4 (10.0%) -
Stomatitis 4 (10.0%) -